CL logo

Colgate-Palmolive (CL)

Profile

Full Name

Colgate-Palmolive Company

Ticker Symbol

CL

Exchange

NYSE

Sector

Consumer Defensive

Industry

Household & Personal Products

Country

United States

IPO

May 2, 1973

Indexes

S&P 500

Website

http://www.colgatepalmolive.com

Employees

34000

Key Details

Price

$92.94(+0.69%)

Market cap

Last Dividend

$0.52

TTM Dividend yield

2.17%

Annual revenue

$20.10B(+3.31% YoY)

Annual EPS

$3.51(+26.71% YoY)

PE ratio

26.25

Next earnings date

Jul 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $92.94
    CL price is $92.94

    30-Day Relative Volume

    1.13
    CL 30-day relative volume is 1.13

    Price Performance

    Price Today change

    +0.69%
    CL price is up +0.69% today

    Price YTD change

    +2.23%
    CL price is up +2.23% since January 1st

    Price 1-year change

    +2.21%
    CL price is up +2.21% year-on-year

    Price 3-year change

    +17.85%
    CL price is up +17.85% over the past 3 years

    Price Range

    Price All-time high

    $109.30
    CL price is currently -14.97% below its historical high of $109.30

    Price 3-year low

    $67.62
    CL price is currently +37.44% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $75.32B
    CL market capitalization is $75.32 billion

    Market cap 3-year change

    +13.98%
    CL market capitalization is up +13.98% over the past 3 years

    Market cap All-time high

    $88.82B
    CL market capitalization is currently -15.20% below its historical high of $88.82 billion

    Market cap sector rank

    95.31%
    CL market capitalization is higher than 95.31% of companies in Consumer Defensive sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.22%
    CL shares outstanding is down -1.22% year-on-year

    Shares Outstanding 3-Year Change

    -3.28%
    CL shares outstanding is down -3.28% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.05
    CL beta is 0.05

    200-day SMA

    $94.49
    CL price is currently -1.64% below its 200-day simple moving average

    50-day SMA

    $91.89
    CL price is currently +1.14% above its 50-day simple moving average

    RSI

    56.25
    CL 14-day relative strength index is 56.25

    Volume

    1.13
    CL 30-day relative volume is 1.13

    ATR

    $1.75
    CL average true range is $1.75

    10-day Historical Volatility

    14.86%
    CL 10-day historical volatility is 14.86%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.52
    CL last dividend was $0.52 per share, with an ex-dividend date of April 17, 2025

    Next Dividend

    -
    CL next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $1.98
    CL annual dividend per share is $1.98

    Dividend per share Sector Rank

    64.65%
    CL annual dividend per share is higher than 64.65% of companies in Consumer Defensive sector

    Dividend per share 1-Year Change

    +3.66%
    CL annual dividend per share is up +3.66% year-on-year

    Dividend per share 3-Year Change

    +10.61%
    CL annual dividend per share is up +10.61% over the past 3 years

    Dividend yield

    Dividend yield

    2.13%
    CL annual dividend yield is 2.13%

    Dividend yield Sector Rank

    24.49%
    CL annual dividend yield is higher than 24.49% of companies in Consumer Defensive sector

    Other

    Payout ratio

    61.92%
    CL annual payout ratio is 61.92%

    Dividends paid

    $1.79B
    CL annual dividends paid is $1.79 billion

    Free cash flow

    $3.55B
    CL annual free cash flow is $3.55 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $20.10B
    CL annual revenue is $20.10 billion

    Revenue Analysts estimate

    $20.27B
    CL annual revenue is currently -0.83% lower than the consensus analysts' forecast

    Revenue 1-year change

    +3.31%
    CL annual revenue is up +3.31% year-on-year

    Revenue Sector rank

    89.53%
    CL annual revenue is higher than 89.53% of companies in Consumer Defensive sector

    EPS

    EPS

    $3.51
    CL annual earnings per share is $3.51

    EPS Analysts estimate

    $3.66
    CL annual earnings per share is currently -4.06% lower than the consensus analysts' forecast

    EPS 1-year change

    +26.71%
    CL annual earnings per share is up +26.71% year-on-year

    EPS Sector rank

    81.96%
    CL annual earnings per share is higher than 81.96% of companies in Consumer Defensive sector

    Profit

    Gross profit

    $12.16B
    CL annual gross profit is $12.16 billion

    Gross margin

    60.50%
    CL annual gross profit margin is 60.50%

    Operating profit

    $4.27B
    CL annual operating income is $4.27 billion

    Operating margin

    21.23%
    CL annual operating profit margin is 21.23%

    Net income

    $2.89B
    CL annual net profit is $2.89 billion

    Net margin

    14.37%
    CL annual net profit margin is 14.37%

    Expenses

    Total expenses

    $15.83B
    CL annual total expenses is $15.83 billion

    Operating expenses

    $7.89B
    CL annual total operating expenses is $7.89 billion

    Cost of goods sold

    $7.94B
    CL annual cost of goods sold is $7.94 billion

    Selling, general & administrative expenses

    $7.73B
    CL annual SGA is $7.73 billion

    Depreciation and amortization

    $605.00M
    CL annual depreciation & amortization is $605.00 million

    Interest expense

    $292.00M
    CL annual interest expense is $292.00 million

    Income tax

    $907.00M
    CL annual income tax is $907.00 million

    EBIT & EBITDA

    EBIT

    $4.25B
    CL annual earnings before interest & taxes is $4.25 billion

    EBITDA

    $4.85B
    CL annual EBITDA is $4.85 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $16.05B
    CL annual total assets is $16.05 billion

    Non current assets

    $10.73B
    CL annual long term assets is $10.73 billion

    Current assets

    $5.32B
    CL annual total current assets is $5.32 billion

    Cash and cash equivalents

    $1.10B
    CL annual cash & cash equivalents is $1.10 billion

    Accounts receivable

    $1.52B
    CL annual accounts receivable is $1.52 billion

    Inventory

    $1.99B
    CL annual inventory is $1.99 billion

    Liabilities

    Total liabilities

    $15.50B
    CL annual total liabilities is $15.50 billion

    Long term liabilities

    $10.40B
    CL annual total long term liabilities is $10.40 billion

    Current liabilities

    $5.10B
    CL annual total current liabilities is $5.10 billion

    Accounts payable

    $1.80B
    CL annual accounts payable is $1.80 billion

    Debt

    Total debt

    $8.72B
    CL annual total debt is $8.72 billion

    Total debt 1-year change

    -3.84%
    CL annual total debt is down -3.84% year-on-year

    Long term debt

    $7.95B
    CL annual long term debt is $7.95 billion

    Short term debt

    $767.00M
    CL annual short term debt is $767.00 million

    Equity & Capital

    Shareholders equity

    $212.00M
    CL annual stockholders equity is $212.00 million

    Book value

    $212.00M
    CL annual book value is $212.00 million

    Retained earnings

    $26.14B
    CL annual retained earnings is $26.14 billion

    Working capital

    $218.00M
    CL annual working capital is $218.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $4.11B
    CL annual cash flow from operations is $4.11 billion

    Cash from operations 1-year change

    +9.67%
    CL annual cash flow from operations is up +9.67% year-on-year

    Cash from investing

    -$534.00M
    CL annual cash flow from investing activities is -$534.00 million

    Cash from investing 1-year change

    +28.03%
    CL annual cash flow from investing activities is up +28.03% year-on-year

    Cash from financing

    -$3.39B
    CL annual cash flow from financing activities is -$3.39 billion

    Cash from financing 1-year change

    -21.34%
    CL annual cash flow from financing activities is down -21.34% year-on-year

    CAPEX

    CAPEX

    $561.00M
    CL annual capital expenditures is $561.00 million

    CAPEX 1-year change

    -20.43%
    CL annual capital expenditures is down -20.43% year-on-year

    Free Cash Flow

    Free cash flow

    $3.55B
    CL annual free cash flow is $3.55 billion

    Free cash flow 1-year change

    +16.64%
    CL annual free cash flow is up +16.64% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    60.50%
    CL annual gross profit margin is 60.50%

    Operating margin

    21.23%
    CL annual operating profit margin is 21.23%

    Net margin

    14.37%
    CL annual net profit margin is 14.37%

    ROA & ROE

    ROA

    17.81%
    CL annual return on assets is 17.81%

    ROE

    384.94%
    CL annual return on equity is 384.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    26.25
    CL price to earnings ratio is 26.25

    PE ratio Sector rank

    61.87%
    CL price to earnings ratio is higher than 61.87% of companies in Consumer Defensive sector

    PB Ratio

    PB ratio

    207.49
    CL price to book ratio is 207.49

    PB ratio Sector rank

    99.22%
    CL price to book ratio is higher than 99.22% of companies in Consumer Defensive sector

    PS Ratio

    PS ratio

    3.78
    CL price to sales ratio is 3.78

    PS ratio Sector rank

    88.69%
    CL price to sales ratio is higher than 88.69% of companies in Consumer Defensive sector

    Enterprise value

    Enterprise value

    $82.48B
    CL enterprise value is $82.48 billion

    Enterprise value Sector rank

    95.67%
    CL enterprise value is higher than 95.67% of companies in Consumer Defensive sector

    EV/EBITDA

    EV/EBITDA

    17.10
    CL EV/EBITDA is 17.10

    EV/EBITDA Sector rank

    80%
    CL EV/EBITDA is higher than 80% of companies in Consumer Defensive sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.04
    CL annual current ratio is 1.04

    Quick ratio

    0.65
    CL annual quick ratio is 0.65

    Leverage

    Debt to equity

    37.50
    CL annual debt to equity ratio is 37.50

    Interest coverage ratio

    14.55
    CL annual interest coverage ratio is 14.55

    Risk & Stability

    Piotroski F-Score

    7
    CL piotroski f-score is 7

    Altman Z-Score

    7.34
    CL altman z-score is 7.34

    Analyst ratings

    Recent major analysts updates

    Apr 28, 25 JP Morgan
    Overweight
    Apr 28, 25 Citigroup
    Buy
    Apr 17, 25 UBS
    Buy
    Apr 11, 25 JP Morgan
    Overweight
    Apr 11, 25 Barclays
    Equal-Weight
    Apr 2, 25 Wells Fargo
    Underweight
    Mar 31, 25 Piper Sandler
    Overweight
    Mar 27, 25 Barclays
    Equal-Weight
    Mar 14, 25 JP Morgan
    Overweight
    Feb 3, 25 UBS
    Buy

    Institutional Ownership

    Screeners with CL included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    Stocks above SMA 50
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Colgate-Palmolive?
    • Does Colgate-Palmolive pay dividends?
    • What sector is Colgate-Palmolive in?
    • What industry is Colgate-Palmolive in?
    • What country is Colgate-Palmolive based in?
    • When did Colgate-Palmolive go public?
    • Is Colgate-Palmolive in the S&P 500?
    • Is Colgate-Palmolive in the NASDAQ 100?
    • Is Colgate-Palmolive in the Dow Jones?
    • When was Colgate-Palmolive's last earnings report?
    • When does Colgate-Palmolive report earnings?
    • Should I buy Colgate-Palmolive stock now?

    What is the ticker symbol for Colgate-Palmolive?

    The ticker symbol for Colgate-Palmolive is NYSE:CL

    Does Colgate-Palmolive pay dividends?

    Yes, Colgate-Palmolive pays dividends. The last payment was $0.52, with an ex-dividend date on April 17, 2025

    What sector is Colgate-Palmolive in?

    Colgate-Palmolive is in the Consumer Defensive sector

    What industry is Colgate-Palmolive in?

    Colgate-Palmolive is in the Household & Personal Products industry

    What country is Colgate-Palmolive based in?

    Colgate-Palmolive is headquartered in United States

    When did Colgate-Palmolive go public?

    Colgate-Palmolive's initial public offering (IPO) was on May 2, 1973

    Is Colgate-Palmolive in the S&P 500?

    Yes, Colgate-Palmolive is included in the S&P 500 index

    Is Colgate-Palmolive in the NASDAQ 100?

    No, Colgate-Palmolive is not included in the NASDAQ 100 index

    Is Colgate-Palmolive in the Dow Jones?

    No, Colgate-Palmolive is not included in the Dow Jones index

    When was Colgate-Palmolive's last earnings report?

    Colgate-Palmolive's most recent earnings report was on Apr 25, 2025

    When does Colgate-Palmolive report earnings?

    The next expected earnings date for Colgate-Palmolive is Jul 25, 2025

    Should I buy Colgate-Palmolive stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page